The Interplay Between Replication Capacity of HIV-1 and Surrogate Markers of Disease

被引:3
作者
Rindler, Audrey E. [1 ,2 ,3 ]
Kusejko, Katharina [1 ,2 ]
Kuster, Herbert [1 ,2 ]
Neumann, Kathrin [1 ,2 ]
Leemann, Christine [1 ,2 ]
Zeeb, Marius [1 ,2 ,3 ]
Chaudron, Sandra E. [1 ,2 ,3 ]
Braun, Dominique L. [1 ,2 ]
Kouyos, Roger D. [1 ,2 ]
Metzner, Karin J. [1 ,2 ]
Gunthard, Huldrych F. [1 ,2 ]
机构
[1] Univ Zurich, Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
[2] Univ Zurich, Inst Med Virol, Zurich, Switzerland
[3] Univ Zurich, Life Sci Zurich Grad Sch, Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
HIV-1; replication capacity; primary HIV-1 isolates; set point viral load; diversity; EARLY ANTIRETROVIRAL THERAPY; INFECTION; VIRULENCE; TRANSMISSION; EFFICIENCY; DIVERSITY; FITNESS; ADULTS; LOAD;
D O I
10.1093/infdis/jiac100
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background HIV-1 replication capacity (RC) of transmitted/founder viruses may influence the further course of HIV-1 infection. Methods RCs of 355 whole-genome primary HIV-1 isolates derived from samples acquired during acute and recent primary HIV-1 infection (PHI) were determined using a novel high-throughput infection assay in primary cells. The RCs were used to elucidate potential factors that could be associated with RC during PHI. Results Increased RC was found to be associated with increased set point viral load (VL), and significant differences in RCs among 13 different HIV-1 subtypes were discerned. Notably, we observed an increase in RCs for primary HIV-1 isolates of HIV-1 subtype B over a 17-year period. Associations were not observed between RC and CD4 count at sample date of RC measurement, CD4 recovery after initiation of antiretroviral treatment, CD4 decline in untreated individuals, and acute retroviral syndrome severity scores. Conclusions These findings highlight that RCs of primary HIV-1 isolates acquired during the acute and recent phase of infection are more associated with viral factors, that is set point VL, than with host factors. Furthermore, we observed a temporal increase in RC for HIV-1 subtype B viruses over a period of 17 years. Using 355 primary HIV-1 isolates of acute and recently HIV-1-infected patients, we elucidated that replication capacity is associated with set point viral load, HIV-1 subtype, and viral diversity, as well as calendar year.
引用
收藏
页码:1057 / 1068
页数:12
相关论文
共 50 条
  • [41] The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation
    Murphy, R. Elliot
    Saad, Jamil S.
    VIRUSES-BASEL, 2020, 12 (05):
  • [42] Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals
    Sakai, Keiko
    Chikata, Takayuki
    Brumme, Zabrina L.
    Brumme, Chanson J.
    Gatanag, Hiroyuki
    Oka, Shinichi
    Takiguchi, Masafumi
    RETROVIROLOGY, 2015, 12
  • [43] Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals
    Keiko Sakai
    Takayuki Chikata
    Zabrina L. Brumme
    Chanson J. Brumme
    Hiroyuki Gatanaga
    Shinichi Oka
    Masafumi Takiguchi
    Retrovirology, 12
  • [44] TNF and HIV-1 Nef: An Intimate Interplay
    Herbein, Georges
    EBIOMEDICINE, 2016, 13 : 25 - 26
  • [45] EFFECT OF ANTIBODY TO HIV-1 TAT PROTEIN ON VIRAL REPLICATION IN-VITRO AND PROGRESSION OF HIV-1 DISEASE IN-VIVO
    FURLINI, MCRG
    VIGNOLI, M
    RAMAZZOTTI, E
    RODERIGO, G
    DEROSA, V
    ZAULI, G
    LOLLI, S
    CAPITANI, S
    LAPLACA, M
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (04): : 408 - 416
  • [46] MICRONUTRIENTS AND HIV-1 DISEASE PROGRESSION
    BAUM, MK
    SHORPOSNER, G
    LU, Y
    ROSNER, B
    SAUBERLICH, HE
    FLETCHER, MA
    SZAPOCZNIK, J
    EISDORFER, C
    BURING, JE
    HENNEKENS, CH
    AIDS, 1995, 9 (09) : 1051 - 1056
  • [47] Role of Cellular DNA Repair Systems in HIV-1 Replication
    Anisenko, A. N.
    Gottikh, M. B.
    MOLECULAR BIOLOGY, 2019, 53 (03) : 313 - 322
  • [48] Inhibitory effects of Sudanese plant extracts on HIV-1 replication and HIV-1 protease
    Hussein, G
    Miyashiro, H
    Nakamura, N
    Hattori, M
    Kawahata, T
    Otake, T
    Kakiuchi, N
    Shimotohno, K
    PHYTOTHERAPY RESEARCH, 1999, 13 (01) : 31 - 36
  • [49] Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response
    Leal, Lorna
    Feher, Csaba
    Richart, Valeria
    Torres, Berta
    Garcia, Felipe
    VACCINES, 2020, 8 (03) : 1 - 20
  • [50] Hormonal contraceptive use and risk of HIV-1 disease progression
    Heffron, Renee
    Mugo, Nelly
    Ngure, Kenneth
    Celum, Connie
    Donnell, Deborah
    Were, Edwin
    Rees, Helen
    Kiarie, James
    Baeten, Jared M.
    AIDS, 2013, 27 (02) : 261 - 267